Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Friend

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Plos One|March 7, 2014
Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancyJustin T Clark, Meredith R Clark, Namdev B Shelke, et al.
AIDS Research and Human Retroviruses|March 5, 2016
Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product DesignKate Morrow Guthrie, Shira Dunsiger, Sara E Vargas, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Simultaneous delivery of tenofovir and acyclovir via an intravaginal ringJohn A Moss, Amanda M Malone, Thomas J Smith, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2012
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxisTodd J Johnson, Meredith R Clark, Theodore H Albright, et al.
Elife|February 4, 2015
Mucosal effects of tenofovir 1% gelFlorian Hladik, Adam Burgener, Lamar Ballweber, et al.
Elife|March 25, 2015
Correction: Musosal effects for tenofovir 1% gelFlorian Hladik, Adam Burgener, Lamar Ballweber, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Plos One|March 7, 2014
Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancyJustin T Clark, Meredith R Clark, Namdev B Shelke, et al.
AIDS Research and Human Retroviruses|March 5, 2016
Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product DesignKate Morrow Guthrie, Shira Dunsiger, Sara E Vargas, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Simultaneous delivery of tenofovir and acyclovir via an intravaginal ringJohn A Moss, Amanda M Malone, Thomas J Smith, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2012
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxisTodd J Johnson, Meredith R Clark, Theodore H Albright, et al.
Elife|February 4, 2015
Mucosal effects of tenofovir 1% gelFlorian Hladik, Adam Burgener, Lamar Ballweber, et al.
Elife|March 25, 2015
Correction: Musosal effects for tenofovir 1% gelFlorian Hladik, Adam Burgener, Lamar Ballweber, et al.
Pageof 6